Kendrith Rowland is an Oncology physician affiliated with Carle Foundation Hospital. OpenAlex indexes 255 publications with 11,644 citations (h-index 56); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
509 W. University Ave.
Urbana, IL 618012500
Telephone
217-383-6636Registry record last updated 24 Jul 2014.
Clinical trials
- Prostate Cancer Survivors and Exercise and Behavioral Counseling
Sponsor: University of Illinois at Urbana-Champaign
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
- MEDIVATION SERVICES LLCProgram year20251 payment
- Daiichi Sankyo Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
42.1%Estrogen Agonist/Antagonist17.4%Tamoxifen Citrate100%Part D≥112 patientsAromatase Inhibitor15.6%Letrozole56%Anastrozole36%Exemestane8%Part D≥63 patients+ 5 more classes in this area
Nervous system
21.3%Phenothiazine5.7%Prochlorperazine Maleate100%Part D≥89 patientsSSRI3.6%Citalopram Hbr43%Escitalopram Oxalate41%Trazodone Hcl16%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
19.7%Serotonin-3 Receptor Antagonist5.9%Ondansetron Odt100%Part D≥100 patientsCorticosteroid5.2%Prednisone100%Part D≥36 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2000–2025 per NIH RePORTER. The latest:
- Carle Cancer Center NCI Community Oncology Research Program (NCORP)
Carle Foundation
FY2025$2,672,824UG1CA189861 - Carle Cancer Center NCI Community Oncology Research Program (NCORP)
Carle Foundation
FY2024$2,257,582UG1CA189861 - Carle Cancer Center NCI Community Oncology Research Program (NCORP)
Carle Foundation
FY2023$2,198,290UG1CA189861
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Llano, MD, PhD
Carle Foundation Hospital
Georgina Cheng, MD, PhD
Carle Foundation Hospital
Charles Davies, MD
Carle Foundation Hospital
Amrendra Miranpuri, MD
Carle Foundation Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”